» Articles » PMID: 26163349

The Extracellular Matrix: Tools and Insights for the "omics" Era

Overview
Journal Matrix Biol
Publisher Elsevier
Date 2015 Jul 12
PMID 26163349
Citations 483
Authors
Affiliations
Soon will be listed here.
Abstract

The extracellular matrix (ECM) is a fundamental component of multicellular organisms that provides mechanical and chemical cues that orchestrate cellular and tissue organization and functions. Degradation, hyperproduction or alteration of the composition of the ECM cause or accompany numerous pathologies. Thus, a better characterization of ECM composition, metabolism, and biology can lead to the identification of novel prognostic and diagnostic markers and therapeutic opportunities. The development over the last few years of high-throughput ("omics") approaches has considerably accelerated the pace of discovery in life sciences. In this review, we describe new bioinformatic tools and experimental strategies for ECM research, and illustrate how these tools and approaches can be exploited to provide novel insights in our understanding of ECM biology. We also introduce a web platform "the matrisome project" and the database MatrisomeDB that compiles in silico and in vivo data on the matrisome, defined as the ensemble of genes encoding ECM and ECM-associated proteins. Finally, we present a first draft of an ECM atlas built by compiling proteomics data on the ECM composition of 14 different tissues and tumor types.

Citing Articles

Refinement of Protein Extraction Protocols for Human Peripheral Nerve Tissue.

Frostadottir D, Welinder C, Perez R, Dahlin L ACS Omega. 2025; 10(5):5111-5118.

PMID: 39959086 PMC: 11822717. DOI: 10.1021/acsomega.4c11373.


Integrins as Key Mediators of Metastasis.

Caceres-Calle D, Torre-Cea I, Marcos-Zazo L, Carrera-Aguado I, Guerra-Paes E, Berlana-Galan P Int J Mol Sci. 2025; 26(3).

PMID: 39940673 PMC: 11816423. DOI: 10.3390/ijms26030904.


Aberrant expression of collagen type X in solid tumor stroma is associated with EMT, immunosuppressive and pro-metastatic pathways, bone marrow stromal cell signatures, and poor survival prognosis.

Famili-Youth E, Famili-Youth A, Yang D, Siddique A, Wu E, Liu W BMC Cancer. 2025; 25(1):247.

PMID: 39939916 PMC: 11823173. DOI: 10.1186/s12885-025-13641-y.


Three-Dimensional Models: Biomimetic Tools That Recapitulate Breast Tissue Architecture and Microenvironment to Study Ductal Carcinoma In Situ Transition to Invasive Ductal Breast Cancer.

Shah S, Osuala K, Brock E, Ji K, Sloane B, Mattingly R Cells. 2025; 14(3).

PMID: 39937011 PMC: 11817749. DOI: 10.3390/cells14030220.


The Microenvironment in DCIS and Its Role in Disease Progression.

Roozitalab M, Prekete N, Allen M, Grose R, Jones J Adv Exp Med Biol. 2025; 1464():211-235.

PMID: 39821028 DOI: 10.1007/978-3-031-70875-6_12.


References
1.
Belluoccio D, Wilson R, Thornton D, Wallis T, Gorman J, Bateman J . Proteomic analysis of mouse growth plate cartilage. Proteomics. 2006; 6(24):6549-53. DOI: 10.1002/pmic.200600191. View

2.
Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

3.
Schreiweis M, Butler J, Kulkarni N, Knierman M, Higgs R, Halladay D . A proteomic analysis of adult rat bone reveals the presence of cartilage/chondrocyte markers. J Cell Biochem. 2007; 101(2):466-76. DOI: 10.1002/jcb.21196. View

4.
Carr S, Abbatiello S, Ackermann B, Borchers C, Domon B, Deutsch E . Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol Cell Proteomics. 2014; 13(3):907-17. PMC: 3945918. DOI: 10.1074/mcp.M113.036095. View

5.
Lech M, Capila I, Kaundinya G . Mass spectrometric methods for the analysis of heparin and heparan sulfate. Methods Mol Biol. 2014; 1229:119-28. DOI: 10.1007/978-1-4939-1714-3_12. View